Companies & Industry »Company News»Company News Details
Company News Details

BSE   03 Mar 15 | 03:32 PM

1530.20 -3 (-0.2%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   03 Mar 15 | 03:55 PM

1530.10 -5.95 (-0.39%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 1,542.95 (-0.83%)
1 Month : Rs 1,543.90 (-0.89%)
1 Year : Rs 1,027.80 (48.88%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
Reliance Inds.901.654.39
TCS2,774.703.92
Bajaj Auto2,120.002.18
Cipla730.602.14
Sun Pharma.Inds.942.402.01

Online Portfolio

You can create Online Portfolio here using the below button.